まとめ
デスフェリオキサミン (D.F.) の皮下注入 ベータ・タラセミア患者の筋肉内注射よりも鉄の損失を助長する. 早期のケレーション療法により,小児における鉄過負荷を予防することができます.
科学分野:
- 血液学 ヘマトロジ
- 薬理学 薬理学とは
- 小児科は小児科です.
背景:
- ホモジゴス型β-タラセミアの患者は,しばしば頻繁な輸血を必要とします.
- 輸血療法は鉄過負荷を引き起こし,ケレーション治療が必要になります.
- デスフェリオキサミン (D.F.) 鉄過負荷の管理に用いられる重要なケラート剤である.
研究 の 目的:
- 筋内 (i.m.) 投与後の尿中の鉄分泌量を比較する. 皮下 (s.c.) デスフェリオキサミン (D.F.) と対照的に 管理. 管理. 管理する.
- D.F.の有効性を評価する. 若いベータ・タラセミア患者における鉄のバランスの達成におけるケレーション.
- 早期のケレーション療法による鉄負荷の予防の可能性を評価する.
主な方法:
- 16人の同同位体のベータタラセミア患者 (10ヶ月から23歳) は,単発のI.M.投与を受けた. ボルス注射または12時間のD.F.のs.c.注入.
- 尿中の鉄分泌量は,D.F.後に測定されました. 管理. 管理. 管理する.
- 鉄のバランスは,鉄の排泄と推定鉄負荷に基づいて評価されました.
主要な成果:
- D.F.の皮下 (s.c.) 輸液を投与する. 同様の筋内 (i.m.) 投与と比較して,鉄の損失が著しく増加しました. すべての年齢層で投与量を決定する.
- 低輸血鉄負荷 (<10g) の6歳未満の小児では,DF. s.c.輸液 (0.5-1g) は,9人の患者のうち8人に鉄のバランスを達成しました.
- 年齢と投与経路は,鉄分泌の有効性に影響を及ぼした.
結論:
- 皮膚下投与デスフェリオキサミン (D.F.) 輸液は,β-タラセミアにおける筋肉内注射よりも鉄分泌のより効果的な経路です.
- 適切なデスフェリオキサミン (D.F.) の早期開始 幼児期のケレーション療法により,漸進的な鉄負荷を防ぐことができます.
- チェレーション療法は,輸血依存性β-タラセミアの管理と鉄過負荷による合併症の予防に不可欠です.
さらに関連する動画
11:59Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies
Published on: September 6, 2017
05:35A Point-of-Care Method with Integrated Decision Support Tool to Estimate Anemia at Population Level
Published on: January 19, 2024
関連する概念動画
Blood Transfusion and Agglutination
Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
Disorders of Erythrocytes
Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
Rh Blood Group
The Rhesus (Rh) antigen is crucial in determining blood groups and ensuring compatibility during blood transfusions.
Blood Transfusion
Blood transfusion is a critical medical procedure that saves lives and treats various medical conditions. It involves transferring blood from a donor to a recipient. This process requires a thorough understanding of the ABO blood group system and its associated antigens and antibodies.
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
Factors Affecting Erythropoiesis
The cardiovascular system regulates the number of erythrocytes in the bloodstream to ensure optimal oxygen transport. It also prevents over-proliferation of these cells, which helps to maintain blood viscosity and flow rate.
Several factors influence the erythrocyte production rate, with tissue oxygen level being among the most critical. Intense exercise or high altitudes can cause tissue hypoxia, which triggers the kidneys to release more erythropoietin (EPO) into the bloodstream.
EPO then...
Several factors influence the erythrocyte production rate, with tissue oxygen level being among the most critical. Intense exercise or high altitudes can cause tissue hypoxia, which triggers the kidneys to release more erythropoietin (EPO) into the bloodstream.
EPO then...
Antiprotozoal Agents
Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...
